FA-S-2-MS-4048

N/A

Report date: 2022/12/28 16:55:05
NME

Base Information

Drug NameFA-S-2-MS-4048
Drug Alias NameFA-S-2-MS-4048FA-S2-MS4048
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionAnaplastic lymphoma kinase inhibitorsFolate receptor alpha antagonists
TargetsFolate receptor alphaAnaplastic lymphoma kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIcahn School Of Medicine At Mount Sinai
China Registration ClassN/A

Develop Information

Active CompaniesIcahn School Of Medicine At Mount Sinai
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A